Heron Therapeutics
HRTX
HRTX
172 hedge funds and large institutions have $242M invested in Heron Therapeutics in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 67 increasing their positions, 38 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
45% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 38
47% less capital invested
Capital invested by funds: $454M → $242M (-$211M)
Holders
172
Holding in Top 10
3
Calls
$297K
Puts
$214K
Top Buyers
| 1 | +$2.49M | |
| 2 | +$2.22M | |
| 3 | +$2.09M | |
| 4 |
Morgan Stanley
New York
|
+$1.99M |
| 5 |
CC
Clearline Capital
New York
|
+$1.46M |
Top Sellers
| 1 | -$22.8M | |
| 2 | -$11.3M | |
| 3 | -$4.16M | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$2.44M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.97M |